Literature DB >> 28372281

Stem-cell therapy for erectile dysfunction.

R Yiou1.   

Abstract

Stem cell-based therapies have been recently investigated in the field of organic erectile dysfunctions, such as those associated with diabetes or the treatment of prostate cancer. The overall aim is to repair the repair the underlying penile cellular damage. Here, we review the rationale behind the use of stem cells injection in post-radical prostatectomy erectile dysfunction (pRP-ED).Radical prostatectomy for prostate cancer induces complex neurologic and vascular injuries that cause one of the most difficult-to-treat forms of erectile dysfunction. Evidence from animal models replicating pRP-ED suggests that intracavernous injection of autologous bone marrow mononuclear cells (BM-MNCs) may represent the first curative approach. Several clinical trials are ongoing and two of them have been completed with encouraging results.

Entities:  

Keywords:  Erectile dysfunction; bone marrow; cavernous nerves; radical prostatectomy

Mesh:

Year:  2017        PMID: 28372281     DOI: 10.3233/BME-171627

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  9 in total

1.  Canadian Urological Association guideline: Erectile dysfunction.

Authors:  Trustin Domes; Borna Tadayon Najafabadi; Matthew Roberts; Jeffrey Campbell; Ryan Flannigan; Phil Bach; Premal Patel; Gavin Langille; Yonah Krakowsky; Philippe D Violette
Journal:  Can Urol Assoc J       Date:  2021-10       Impact factor: 1.862

2.  Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy.

Authors:  Joao P Zambon; Manish Patel; Ashok Hemal; Gopal Badlani; Karl-Erik Andersson; Renata S Magalhaes; Shannon Lankford; Ashley Dean; James Koudy Williams
Journal:  Neurourol Urodyn       Date:  2018-08-31       Impact factor: 2.696

3.  Vision and Strategies for Men's Health Research in an Aging Society.

Authors:  Jae Seog Hyun
Journal:  World J Mens Health       Date:  2018-09       Impact factor: 5.400

4.  Pharmacological Advances in the Management of Sexual Dysfunction.

Authors:  M S Reddy; M Starlin Vijay
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

5.  Administration of Adipose Derived Mesenchymal Stem Cells and Platelet Lysate in Erectile Dysfunction: A Single Center Pilot Study.

Authors:  Vassilis Protogerou; Efstathios Michalopoulos; Panagiotis Mallis; Ioanna Gontika; Zetta Dimou; Christos Liakouras; Catherine Stavropoulos-Giokas; Nikolaos Kostakopoulos; Michael Chrisofos; Charalampos Deliveliotis
Journal:  Bioengineering (Basel)       Date:  2019-03-05

6.  Global Research Trends on Prostate Diseases and Erectile Dysfunction: A Bibliometric and Visualized Study.

Authors:  Chengquan Ma; Hao Su; Hongjun Li
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

Review 7.  Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials.

Authors:  Mudassir M Wani; Bhavan P Rai; William Richard Webb; Sanjeev Madaan
Journal:  Ther Adv Urol       Date:  2022-03-29

8.  LncRNA MALAT1 facilitates BM-MSCs differentiation into endothelial cells via targeting miR-206/VEGFA axis.

Authors:  Xiang Sun; Longhua Luo; Jiarui Li
Journal:  Cell Cycle       Date:  2020-10-29       Impact factor: 4.534

9.  Transplantation of induced pluripotent stem cell-derived mesenchymal stem cells improved erectile dysfunction induced by cavernous nerve injury.

Authors:  Zehong Chen; Xiaoyan Han; Xi Ouyang; Jiafeng Fang; Xuna Huang; Hongbo Wei
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.